NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have
commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline
to request that the court appoint you as lead plaintiff.
Prothena Corporation (NASDAQ:PRTA)
Lead Plaintiff Deadline: July 16, 2018
Class Period: October 15, 2015 and April 20, 2018
Get additional information about PRTA: http://www.wongesq.com/pslra-c/prothena-corporation-2?wire=3.
Symantec Corp. (NASDAQ:SYMC)
Lead Plaintiff Deadline: July 16, 2018
Class Period: May 20, 2017 and May 10, 2018
Get additional information about SYMC: http://www.wongesq.com/pslra-c/symantec?wire=3.
Micro Focus International plc (NYSE:MFGP)
Lead Plaintiff Deadline: July 23, 2018
Class Period: September 1, 2017 and March 19, 2018; pursuant to the August 4 and August 22, 2017 Prospectuses
Get additional information about MFGP: http://www.wongesq.com/pslra-c/micro-focus-international-plc?wire=3.
Aegean Marine Petroleum Network Inc. (NYSE:ANW)
Lead Plaintiff Deadline: August 6,
2018
Class Period: April 28, 2016 and June 4, 2018
Get additional information about ANW: http://www.wongesq.com/pslra-c/aegean-marine-petroleum-network-inc?wire=3.
Ormat Technologies, Inc. (NYSE:ORA)
Lead Plaintiff Deadline: August 8, 2018
Class Period: August 8, 2017 and May 15, 2018
Get additional information about ORA: http://www.wongesq.com/pslra-c/ormat-technologies-inc-2?wire=3.
PG&E Corporation (NYSE:PCG)
Lead Plaintiff Deadline: August 13, 2018
Class Period: April 29, 2015, and June 8, 2018
Get additional information about PCG: http://www.wongesq.com/pslra-c/pge-corporation?wire=3.
TAL Education Group (NYSE:TAL)
Lead Plaintiff Deadline: August 17, 2018
Class Period: April 26, 2018 and June 13, 2018
Get additional information about TAL: http://www.wongesq.com/pslra-c/tal-education-group?wire=3.
Flex Pharma, Inc. (NASDAQ:FLKS)
Lead Plaintiff Deadline: August 20,
2018
Class Period: November 6, 2017 and June 12, 2018
Get additional information about FLKS: http://www.wongesq.com/pslra-c/flex-pharma-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving
financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
